Delivery Order SPE2DB20D1004-SPE2DB22FF0P5
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mercaptopurine 50 mg tablets, with a ceiling value of $2,835.68 and a period of performance through June 26, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
- This is a $2,211.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 250-count bottles of the drug mercaptopurine 50 mg tablets. The contract has an ultimate completion date of May 23, 2025 and is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of MERCAPTOPURINE 50 MG TABLET 250S. The contract, valued at $2,860.09, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 13, 2023. The...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,641.84, is for the delivery of 4,568,100 units of the prescription medication mercaptopurine 50 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,206.16 firm fixed-price delivery order is for the supply of 250 count tablets of the pharmaceutical product Mercaptopurine 50 mg. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,314,186 units of the pharmaceutical drug mercaptopurine 50 mg tablets, with a ceiling value of $2,872.84. The contract has a firm fixed-price pricing type and an ultimate completion date of April 18, 2024. There is no set-aside designation indicated for this award. Amerisourcebergen is a major supplier of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The $1,552.39 firm fixed-price contract is for the supply of Mercaptopurine 50 mg tablets. The contract has an ultimate completion date of December 15, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs, particularly within the military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,417.53 to AmerisourceBergen Drug Corp for the supply of Mercaptopurine 50 mg tablets (250 count) under a firm fixed-price contract. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is classified as a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,927.08, is for the supply of Mercaptopurine 20 mg/mL suspension, a medication used to treat certain types of cancer. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,767.74 delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Mercaptopurine 20 mg/ml suspension in 100 ml quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of April 24, 2025, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. Mercaptopurine is a critical immunosuppressant and chemotherapy medication used in military and...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FF0P5Delivery Order
This federal contract award, valued at $5,500.45, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4555797501 - Mercaptopurine 50 mg Tablets in 250-count packages. The contract has a completion date of December 29, 2021 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and Department of Justice, valued at up to $999,999,999 and $750,000 respectively, to provide a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 12/28/21 |